Androgen News and Research

RSS

New research indicates birth control pill could cause long-term problems with testosterone

In the January issue of The Journal of Sexual Medicine, researchers have published a new investigation measuring sex hormone binding globulin (SHBG) before and after discontinuation of the oral contraceptive pill.

4 Jan 2006

New therapies for prostate cancer

A Dutch study suggested treating prostate cancer patients with higher doses of radiotherapy significantly improved patient outcome and treatment over a five-year period.

3 Nov 2005

DN-101 may protect against major side effects of chemotherapy

Men with advanced prostate cancer who take an experimental, high-dose vitamin D pill with chemotherapy live about eight months longer than those receiving chemotherapy and placebo, according to a new study.

3 Nov 2005

Calcitriol - promising chemopreventive agent that may prevent prostate cancer

The active metabolite of vitamin D, calcitriol, and other vitamin D analogs are promising chemopreventive agents that may prevent prostate cancer, according to a study presented today at the American Association for Cancer Research's 4th annual Frontiers in Cancer Prevention Research meeting in Baltimore.

3 Nov 2005

Role of alpha tocopherol associated protein in prostate cancer

Researchers have identified a protein that disrupts an important signaling pathway in prostate cancer cells and suppresses growth of the cancer.

1 Nov 2005

Researchers identify biomarker that indicates a more agressive form of prostate cancer

Staging factors for prostate cancer such as PSA and the Gleason score are extremely useful in predicting prostate cancer outcome," explained Pollack. "However, new biomarkers hold promise in strengthening our ability to predict response to treatment. By identifying the more virulent forms of prostate cancer, we may be able to tailor treatment or develop therapies to target the abnormalities identified."

17 Oct 2005

Development of aggressive forms of prostate cancer may be influenced by environmental effects that occur early in life

How heavy a man is at the time he is diagnosed with prostate cancer, as well as his history of weight gain, appear to play significant roles in how aggressive his cancer may become, say researchers at the University of Texas M. D. Anderson Cancer Center.

3 Oct 2005

Recent evidence suggests caution in prescribing hormone therapy for breast cancer

One of the most effective new treatments for breast cancer is a hormone therapy. Aromatase inhibitors work by powerfully blocking the conversion of androgen precursors into estrogens, which lowers estradiol levels in the bloodstream and estrogen levels in peripheral tissues.

4 Sep 2005

Calcium fights prostate cancer

Calcium, more familiar in its role as one of the building blocks of the body, is being enlisted as a tool in the fight against prostate cancer.

15 Aug 2005

Activated Stat5 protein in prostate cancer can predict outcome, may help target treatment

Researchers from Lombardi Comprehensive Cancer Center at Georgetown University found that testing for an activated Stat5 protein in prostate tumor tissue effectively predicts which men have a form of prostate cancer that may become more aggressive and life threatening.

15 Aug 2005

Researchers identify protein called EMP-1 that is present in the tumors of patients who fail to respond to treatment with gefitinib

By the time the human genome was mapped, cancer researchers had already begun investigating the proteins that were encoded by these newly identified genes.

9 Aug 2005

Rate of increase in PSA value predicts risk of death following radiation therapy

Men who have a higher rate of increase in their PSA value in the year prior to their prostate cancer diagnosis have a significantly higher risk of death following radiation therapy, according to a study in the July 27 issue of JAMA: The Journal of the American Medical Association.

26 Jul 2005

Sex hormone levels not linked to low sexual desire

No single androgen (sex hormone) level was found to be predictive of low sexual function in women, according to a study in the July 6 issue of JAMA.

6 Jul 2005

Latest research on men's health issues, treatments and lifestyle practices

Today, leading researchers are gathering at the annual meeting of The Endocrine Society in San Diego to present the latest research on men's health issues, treatments and lifestyle practices. New findings could help doctors identify risks and treat men's conditions more effectively.

6 Jun 2005

Study links TNF to androgen deficiency in rheumatoid arthritis patients and suggest a novel pathway in inflammation

A protein involved in multiple cell functions, tumor necrosis factor (TNF) is perhaps best known for provoking destructive inflammation. Recently, drugs blocking the action of TNF have shown promise in the early treatment of rheumatoid arthritis (RA).

2 Jun 2005

Bald men can blame mum!

Despite an enormous range of treatments, obscure lotions and tinctures there appears to be very few successful counter-measures for hair loss in men. Beginning with receding hairlines, every second man suffers from hair loss to some degree, and it has always been suspected that hereditary factors are important in causing hair loss.

22 May 2005

Impact of oral contraceptives not immediately reversible after discontinuation

Hormonal changes induced by oral contraceptives (OC) are not immediately reversible after discontinuation of use, according to new research issued today at the American Association of Clinical Endocrinologists (AACE) Fourteenth Annual Meeting and Clinical Congress.

18 May 2005

Vitamin D, taxotere combination promising for advanced prostate cancer

Results of a new study strongly suggest that DN-101, a new high-dose calcitriol pill designed specifically as a cancer therapy, given in combination with docetaxel (Taxotere) extends the lives of men with advanced prostate cancer.

17 May 2005

Taxotere shows significant survival benefit in the treatment of advanced gastric cancer

Final results from the largest international study in the treatment of advanced stomach cancer, also known as gastric cancer, demonstrated that patients who received a Taxotere (docetaxel) Injection Concentrate-based chemotherapy regimen (Taxotere, cisplatin and 5-fluorouracil) had significantly improved overall survival rates compared to patients who received a standard treatment (cisplatin and 5- fluorouracil).

16 May 2005

Long-term outcomes promising for patients with localized, low-grade prostate cancer

A study that includes 20 years of follow-up does not support aggressive treatment for localized, low-grade prostate cancer, with data indicating a small risk of progression of this grade of cancer, according to a study in the May 4 issue of JAMA.

3 May 2005

Androgen News and Research

New research indicates birth control pill could cause long-term problems with testosterone

New therapies for prostate cancer

DN-101 may protect against major side effects of chemotherapy

Calcitriol - promising chemopreventive agent that may prevent prostate cancer

Role of alpha tocopherol associated protein in prostate cancer

Researchers identify biomarker that indicates a more agressive form of prostate cancer

Development of aggressive forms of prostate cancer may be influenced by environmental effects that occur early in life

Recent evidence suggests caution in prescribing hormone therapy for breast cancer

Calcium fights prostate cancer

Activated Stat5 protein in prostate cancer can predict outcome, may help target treatment

Researchers identify protein called EMP-1 that is present in the tumors of patients who fail to respond to treatment with gefitinib

Rate of increase in PSA value predicts risk of death following radiation therapy

Sex hormone levels not linked to low sexual desire

Latest research on men's health issues, treatments and lifestyle practices

Study links TNF to androgen deficiency in rheumatoid arthritis patients and suggest a novel pathway in inflammation

Bald men can blame mum!

Impact of oral contraceptives not immediately reversible after discontinuation

Vitamin D, taxotere combination promising for advanced prostate cancer

Taxotere shows significant survival benefit in the treatment of advanced gastric cancer

Long-term outcomes promising for patients with localized, low-grade prostate cancer

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News